These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9856834)

  • 1. An experimental model for interpreting percutaneous penetration of oligonucleotides that incorporates the role of keratinocytes.
    Brand RM; Haase K; Hannah TL; Iversen PL
    J Invest Dermatol; 1998 Dec; 111(6):1166-71. PubMed ID: 9856834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of size and sequence on the iontophoretic delivery of oligonucleotides.
    Brand RM; Wahl A; Iversen PL
    J Pharm Sci; 1998 Jan; 87(1):49-52. PubMed ID: 9452967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iontophoretic delivery of a telomeric oligonucleotide.
    Brand RM; Iversen PL
    Pharm Res; 1996 Jun; 13(6):851-4. PubMed ID: 8792421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and quantification of polyethylenimine oligodeoxynucleotide complexes in human skin after iontophoretic delivery using confocal scanning laser microscopy.
    Brus C; Santi P; Colombo P; Kissel T
    J Control Release; 2002 Dec; 84(3):171-81. PubMed ID: 12468220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of a FITC-labeled phosphorothioate oligodeoxynucleotide in the skin after topical delivery by iontophoresis and electroporation.
    Regnier V; Préat V
    Pharm Res; 1998 Oct; 15(10):1596-602. PubMed ID: 9794503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric and microscopic characterization of the uptake and distribution of phosphorothioate oligonucleotides in human keratinocytes.
    Wingens M; van Hooijdonk CA; de Jongh GJ; Schalkwijk J; van Erp PE
    Arch Dermatol Res; 1998 Mar; 290(3):119-25. PubMed ID: 9558486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin.
    Oldenburg KR; Vo KT; Smith GA; Selick HE
    J Pharm Sci; 1995 Aug; 84(8):915-21. PubMed ID: 7500273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of iontophoresis for transdermal delivery of NF-kappaB decoy oligonucleotides.
    Hashim II; Motoyama K; Abd-Elgawad AE; El-Shabouri MH; Borg TM; Arima H
    Int J Pharm; 2010 Jun; 393(1-2):127-34. PubMed ID: 20417264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parameters controlling topical delivery of oligonucleotides by electroporation.
    Regnier V; Le Doan T; Préat V
    J Drug Target; 1998; 5(4):275-89. PubMed ID: 9713977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live confocal microscopy of oligonucleotide uptake by keratinocytes in human skin grafts on nude mice.
    White PJ; Fogarty RD; Liepe IJ; Delaney PM; Werther GA; Wraight CJ
    J Invest Dermatol; 1999 Jun; 112(6):887-92. PubMed ID: 10383734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iontophoresis of bases, nucleosides, and nucleotides.
    van der Geest R; Hueber F; Szoka FC; Guy RH
    Pharm Res; 1996 Apr; 13(4):553-8. PubMed ID: 8710745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal delivery of antisense compounds.
    Brand RM; Iversen PL
    Adv Drug Deliv Rev; 2000 Oct; 44(1):51-7. PubMed ID: 11035197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antisense oligonucleotides on cytokine release from human keratinocytes in an in vitro model of skin.
    Crooke RM; Crooke ST; Graham MJ; Cooke ME
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):85-93. PubMed ID: 8806873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal delivery of phosphorodiamidate Morpholino oligomers across hairless mouse skin.
    Pannier AK; Arora V; Iversen PL; Brand RM
    Int J Pharm; 2004 May; 275(1-2):217-26. PubMed ID: 15081152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermal delivery of topically applied oligonucleotides via follicular transport in mouse skin.
    Dokka S; Cooper SR; Kelly S; Hardee GE; Karras JG
    J Invest Dermatol; 2005 May; 124(5):971-5. PubMed ID: 15854038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport behavior of hairless mouse skin during constant current DC iontophoresis, part 2: iontophoresis of nonionic molecules with cotransport of polystyrene sulfonate oligomers.
    Liddell MR; Li SK; Higuchi WI
    J Pharm Sci; 2011 Jul; 100(7):2816-25. PubMed ID: 21455977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical and transdermal delivery of antisense oligonucleotides.
    Brand RM
    Curr Opin Mol Ther; 2001 Jun; 3(3):244-8. PubMed ID: 11497348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the cellular internalization of thermolytic phosphorothioate DNA oligonucleotide prodrugs.
    Jain HV; Takeda K; Tami C; Verthelyi D; Beaucage SL
    Bioorg Med Chem; 2013 Oct; 21(20):6224-32. PubMed ID: 23755885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.